-
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
Friday, September 15, 2023 - 5:14pm | 1039The long-awaited psychedelic-assisted treatment alternative for Post-Traumatic Stress Disorder (PTSD) is moving closer to federal approval. The Multidisciplinary Association for Psychedelic Studies (MAPS) and its private subsidiary company, MAPS PBC shared the publication of the...
-
Dua Lipa Interviews 'Queen Of Psychedelics' Amanda Feilding On Her 6-Decade Exploration Of Psychoactive Drugs
Monday, August 7, 2023 - 5:12pm | 703Multi-awarded singer Dua Lipa has been interviewing some interesting folks in her BBC’s “At Your Service” series. This season she invited psychedelics pioneering researcher and advocate Amanda Feilding, aka “the Queen of Psychedelics” or also “The High Priestess...
-
California's Reform Update: Ballot Initiative Calls For $5B In Research, Legal Psilocybin Campaign On Track, And Local Moves
Tuesday, July 25, 2023 - 3:27pm | 839$5B For Research Accelerating Federal Legalization The Californians for Treatments, Research, Education, Access and Therapies (TREAT) for Psychedelic Assisted Therapy and Cures officially filed a proposal creating a $5 billion state agency to fund and promote psychedelics research to the state...
-
FDA Guidance On Psychedelics Research, Alabama Cannabis Regulator Under Fire And More Reg Updates
Monday, June 26, 2023 - 12:23pm | 831Legal Hurdle Around Alabama Cannabis Licensing Process Heats Up Alabama Medical Cannabis Commission Is getting sued by yet another cannabis company as a legal hurdle around the state's flawed cannabis licensing process heats up. Alabama Always LLC filed the lawsuit in Montgomery County Circuit...
-
AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
Thursday, June 8, 2023 - 5:25pm | 782As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help. AI-Infused Research Partnerships The Institute of Biomedical Research Corp. (OTCMKTS: MRES) is using AI algorithms, machine learning and...
-
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
Friday, May 5, 2023 - 2:49pm | 285Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction. Accelerating Research At a...
-
Studying Psychedelics As Medicine: UK University Offers Postgrad Course On Clinical Use
Tuesday, April 25, 2023 - 5:32pm | 205The University of Exeter is launching a new postgraduate program on psychedelics, called "Psychedelics: Mind, Medicine, and Culture." The program aims to train therapists, mental health advocates, and healthcare workers on how to safely work with psilocybin, LSD, MDMA, and other...
-
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
Wednesday, November 30, 2022 - 1:58pm | 402Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc. have submitted the first-ever Phase 2a Clinical Trial Application (CTA) to test safety and efficacy of oral microdose of proprietary psilocybin...
-
Psychedelic Research & Fed Funding Are Priorities, Nat Institute Of Mental Health Sets Guidelines & Research Goals
Monday, November 28, 2022 - 1:27pm | 512The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants, reported Marijuana Moment. NIMH’s notice of information states...
-
Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021
Wednesday, May 11, 2022 - 10:21am | 370Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or $0.50 loss per share. For comparison, net loss in the same period of 2021 was $12.7 million or...
-
Top 5 Most Influential Psychedelic Studies
Tuesday, March 29, 2022 - 5:08pm | 1743This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming...